D. Mero

Growth at reasonable price, healthcare, newsletter provider
D. Mero
Growth at reasonable price, healthcare, newsletter provider
Contributor since: 2012
Company: N/A
3/4/15
D. Mero
Notes from my discussion with $NEPT new CEO Jim Hamilton http://bit.ly/1M7no3S $ACST
11/18/14
D. Mero
9 Insiders Purchase Shares Of Neptune On The Open Market $NEPT http://seekingalpha.com/a/1lpoj
9/19/14
D. Mero
Overstock.com Offers E-Commerce Upside, Yet Not Receiving Valuation Premiums Of Peers $OSTK http://seekingalpha.com/a/1hr4l
9/16/14
D. Mero
Proceed With Caution As Markets Reaching Tipping Point According To These Indicators http://seekingalpha.com/a/1hjad
8/13/14
D. Mero
Ebix Fueling Growth By Going Back To Its Bread And Butter $EBIX http://seekingalpha.com/a/1fvqr
8/7/14
D. Mero
Organovo Preparing For Product Launch With Necessary Prerequisite Steps $ONVO http://seekingalpha.com/a/1fc89
7/25/14
D. Mero
Inovio Data Not A Home Run, But Got Company In Great Scoring Position $INO http://seekingalpha.com/a/1e85h
7/24/14
D. Mero
After Puma's Huge Spike, Is A Potential Acquisition Already Priced In? $PBYI http://seekingalpha.com/a/1e3g1
7/16/14
D. Mero
Lexmark Valuation Does Not Incorporate Lacking Growth $LXK http://seekingalpha.com/a/1dp9h
7/16/14
D. Mero
AntriaBio Presents Vast Upside With Disruptive Once-Weekly Insulin $ANTB-OLD http://seekingalpha.com/a/1do9n
7/9/14
D. Mero
Gigamon's Weak Guidance: An Opportunity To Scoop Up Cheap Shares $GIMO http://seekingalpha.com/a/1dfy7
7/1/14
D. Mero
GoPro IPO: Good Exit Point For Existing Shareholders, No Entry Point For New Investors $GPRO http://seekingalpha.com/a/1d7dl
5/29/14
D. Mero
Substance Over Style: How Niche Companies Alliqua And Horizon Are Being Overlooked $HZNP http://seekingalpha.com/a/1c32z
5/13/14
D. Mero
Curated Music Influencing Apple's Jump Into Streaming $AAPL http://seekingalpha.com/a/1bgol
5/8/14
D. Mero
Organovo's Bioprinting More Than A 'Stupid Exercise' $ONVO http://seekingalpha.com/a/1b74f
4/15/14
D. Mero
Activist Trying To Unlock A Potential 65% Upside In Neptune $NEPT http://seekingalpha.com/a/19wsn
4/4/14
D. Mero
With Favorable Shift In Advance Wound Care Market, Alliqua Could Grow Revenues To $35M Within 3 Years $ALQA http://seekingalpha.com/a/19kdp
4/16/14
Wish I would have gotten in....Took the bait on some other names yesterday. Maybe I will get a second chance.
yaa i wish i got more @ 6.5 :-)
3/26/14
D. Mero
Mediwound IPO Suggests Upside For Others In Wound Care $MDWD http://seekingalpha.com/a/198x7
3/12/14
D. Mero
3D Printing Investors Should Do As Insiders And Sell Proto Labs; Buy Alphaform Instead $AFRMF http://seekingalpha.com/a/18nhj
3/4/14
D. Mero
Marketing Strategy Could Distinguish Neptune With Industry Leading Status $NEPT http://seekingalpha.com/a/189x7
2/22/14
D. Mero
Ekso And 3D Printing Have More In Common Than Just A Partnership $EKSO http://seekingalpha.com/a/17phd
2/21/14
D. Mero
Placenta Based Treatments Crowding Out Legacy Products In Wound Care $ALQA http://seekingalpha.com/a/17ovz
1/21/14
D. Mero
$ONVO opportunities warant the current valuation http://seekingalpha.com/a/15xv1
1/21/14
RBCC is a much better pick in terms of value for tissue engineering.
rdunga: How do you figure? Morningstar says re RBCC: "Rainbow Coral Corp operates a retail fish store & coral farm facility." What gives??
1/21/14
D. Mero
$NEPT $ENZY $ACST $AMRN New article on the omega-3 market and involved players http://seekingalpha.com/a/15y9h
1/21/14
D. Mero
Neptune Erecting A Moat In Omega-3; Shares Undervalued $NEPT http://seekingalpha.com/a/15y9h
1/21/14
D. Mero
Can Organovo's opportunities warrant its valuation? http://seekingalpha.com/a/15xv1
1/21/14
D. Mero
Organovo's Opportunities Validate Rising Valuation $ONVO http://seekingalpha.com/a/15xv1
12/20/13
D. Mero
$INO interview with CEO Dr.Joseph Kim http://seekingalpha.com/a/14xjj
12/17/13
D. Mero
$NUAN: How the transition to subscription revenue has been misunderstood by the market http://seekingalpha.com/a/14sn5
12/14/13
D. Mero
$HOLX: Oversight changes are a result of Icahn effect. Won't happen overnight, but shareholders will be rewarded. Next up: $NUAN
12/13/13
D. Mero
$NUAN: Leader in a growing market and Icahn 20% stake make company an attractive turnaround candidate
12/13/13
Dragon!